导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -5.93% | 744/1050 |
| 近一周 | -2.59% | 842/1104 |
| 近一月 | -0.17% | 140/1103 |
| 近一季 | -1.56% | 345/1092 |
| 近半年 | -8.87% | 744/1070 |
| 近一年 | -6.50% | 688/1018 |
| 近两年 | 26.98% | 713/926 |
| 近三年 | 2.52% | 655/834 |
| 成立以来 | 401.52% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-1.64% 606/1070 |
-11.50% 947/1101 |
- - |
- - |
| 2025 | 10.72% 821/1065 |
2.25% 627/1014 |
2.37% 478/1038 |
6.28% 917/1050 |
-0.48% 483/1065 |
| 2024 | 7.34% 347/1011 |
-2.31% 436/960 |
-1.88% 428/983 |
19.26% 79/991 |
-6.10% 738/1011 |
| 2023 | -12.67% 424/952 |
1.40% 546/880 |
-4.55% 498/895 |
-2.42% 174/915 |
-7.52% 726/952 |
| 2022 | -7.01% 49/867 |
-12.63% 167/773 |
7.37% 381/806 |
-7.48% 119/845 |
7.13% 135/867 |
| 2021 | 11.33% 225/740 |
10.85% 7/580 |
2.06% 512/659 |
-5.77% 380/704 |
4.43% 246/740 |
| 2020 | 53.76% 222/554 |
-7.70% 350/419 |
23.68% 217/466 |
18.34% 76/517 |
13.81% 231/554 |
| 2019 | 44.36% 189/410 |
27.91% 497/1149 |
-0.03% 339/1231 |
4.25% 215/390 |
8.29% 225/410 |
| 2018 | -16.75% 38/349 |
- - |
- - |
- - |
-10.11% 303/1080 |
| 2017 | 24.48% 68/285 |
- - |
- - |
- - |
- - |
| 2016 | -3.40% 37/205 |
- - |
- - |
- - |
- - |
| 2015 | 59.12% 14/151 |
- - |
- - |
- - |
- - |
| 2014 | 32.33% 7/24 |
- - |
- - |
- - |
- - |
| 2013 | -8.18% 20/21 |
- - |
- - |
- - |
- - |
| 2012 | 24.97% 2/157 |
- - |
- - |
- - |
- - |
| 2011 | -18.19% 21/102 |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 国富中小盘股票A VS. 东吴新产业精选股票A(580008) |